CNBC   |  April 29, 2013

Most Undervalued Pharma Stock Is Merck: Pro

Pfizer will report earnings on Tuesday before the market open. The FMHR traders debate the bull and the bear case for the stock. Barbara Ryan, FTI Strategic Communications, shares her recommendations for investing in pharma stocks now.

Share This:

Sorry, we do not have a transcript available for this video at this time.